Despite the slightly warmer weather and longer periods of sunshine, we are still in the depths of cold and flu season, a ...

Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

According to officials from the Wheeling-Ohio County Health Department, there is a spike in RSV, Influenza A, and Norovirus ...

Fact checked by Nick Blackmer Despite a temporary freeze on public communications, the Centers for Disease Control and ...

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

7. New RSV prevention options for infants and pregnant mothers A new RSV prevention option for infants was introduced in 2023: the monoclonal antibody treatment Beyfortus (nirsevimab). This shot is ...